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An 8.0-kb EcoRI fragment of the human immunoglobulin (Ig) L light chain locus carrying the Ke-Oz- and 
Ke-Oz+ constant region genes and flanking sequences was studied for the presence of a transcriptional en- 
hancer. Two types of assays were used. In the first, we measured the ability of recombinant plasmids car- 
rying the 8.0-kb Ig fragment covalently linked to the aminoglycoside phosphotransferase (aph) gene to 
transform mouse myeloma or mouse fibroblast cells to geneticin resistance. In the second, we used RNA 
spot and Northern blot hybridization analyses to determine the relative levels of aph specific RNA transient- 
ly expressed after DNA transfection. In tibroblast cells, the transformation frequencies were independent 
of the presence of the Ig fragment in the vector and there was no difference in the level of transient expres- 
sion of the aph gene. In myeloma cells, the Ig fragment enhanced at least IO-fold both the number of trans- 
formants and the level of aph gene expression over that obtained with vector alone. These results indicate 
the presence of a tissue-specific transcriptional enhancer in the 8.0-kb EcoRI fragment of the human Ig Cl 
locus. 
Enhancer Immunoglobulin Gene transfer 
1. INTRODUCTION 
Transcriptional enhancers are positive regula- 
tory elements which have the following common 
properties: They are short &-acting DNA se- 
quences which affect transcription of nearby 
genes. Their action is independent of whether they 
are located upstream or downstream of the gene 
concerned and does not depend on the enhancer 
orientation. They are effective over long distances 
and can display cell type and species specificity. 
Comparison of several enhancer sequences ug- 
gests they have a consensus core sequence, 
GXTGTGGm [ 11. 
Enhancers were first discovered as components 
of some viral genomes, viz., SV40 [2,3], polyoma 
virus [4,5], bovine papillomavirus (BPV-1) [6], 
retroviruses [7,8] and Herpes simplex virus 
(HSV-1) [9]. Studies in several laboratories have 
demonstrated the presence of cellular enhancers in 
the mouse Ig heavy chain locus [lo-121 and in the 
mouse Ig K light chain locus [ 131. Similarly, a 
human tissue-specific enhancer element has been 
described in the human Ig heavy chain locus in a 
non-Hodgkin’s lymphoma cell line where this 
enhancer is translocated next to, and activates, the 
cellular myc oncogene [ 141. 
Since enhancers have been found in the constant 
regions of both Ig heavy and Ig Ck loci we decided 
to examine whether a similar transcriptional 
regulatory element is present in the Ig CA locus. 
Results are presented in this report. 
2. MATERIALS AND METHODS 
2.1. Cells and plasmids 
Mouse LATK- fibroblast, mouse AG653 and 
rat Y3AG-1-2-3 myeloma cells were grown in 
monolayers in Ham’s SF12 medium (Flow 
Laboratories) containing 15% Hyclone serum 
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(Sterile Systems). The bacterial strain ~~c~e~~c~~~ 
coli HblOl carrying the plasmid pNff was a gift 
from P. Montague. The lambda recombinant 
phage A22-h5 which contains an 8.0-kb EcoRI 
fragment carrying the Ke-Oz- and Ke-Oz+ genes 
of human Ig CA locus was isolated from a 
chromosome 22 library [15] and was obtained 
from T. Rabbits [16]. The insert was subsequently 
cloned in the single EcoRI site of plasmid pUC8 to 
obtain plasmid pUL1. Plasmids pAM91 [17] and 
pHR28 (A. Sproul and G. Birnie, unpublished) 
carried mouse actin and human ribosomal DNA 
sequences, respectively. 
2.2. Plasmid constructions (fig. I) 
The 8.0-kb fragment of human genomic Ig CA 
DNA was isolated after digestion of recombinant 
pUL1 with EcoRI and separation from the 
bacterial plasmid DNA by agarose gel elec- 
trophoresis. The pNel vector DNA was restricted 
with EcoRI, treated with alkaline phosphatase [22] 
and mixed with the 8.0-kb human DNA fragment 
in equimolar proportions. The two DNAs were 
ligated with T4 DNA ligase and used to transform 
E, co/i HblOI [23]. Ampicillin-resistant clones 
were obtained and screened by the hybridization 
technique in [24] using the human insert DNA as 
a probe. The orientation of the insert Ig CA DNA 
was determined by restriction enzyme digests. 
Recombinant plasmids pN~1Gl and pNeIG2 con- 
tained the human DNA in the 5’-3’ or 3’-5’ orien- 
tation, respectively, relative to the aph gene. 
2.3. DNA-mediated gene transfer 
Transfections of LATK- and AG653 mouse 
cells were carried out using the calcium phosphate 
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Fig. 1. Physical map of the human Ig CA locus and structures of aph recombinanis. The arrangement of a cluster of 
6 Ch genes (filled boxes) along chromosomal DNA is shown at the top [18]. Plasmid pNe1 contains the bacterial TnS 
encoded aph gene derived from plasmid, pAG60 [ 19). The aph gene is under the 5’ transcriptional control of the human 
epsilon globin gene promoter [20] and the 3’-polyadenylation signal of HSV-1 rk gene. Plasmid pNe1 was constructed 
by P. Montague. The epsilon globin promoter of 197-bp BamHl-PvuII fragment was converted to a Hind111 fragment 
using molecular linkers and was derived from plasmid pTKE1 [21]. The arrows indicate the direction of transcription; 
the broken line indicates plasmid pBR322 sequences; the filled box the aph structural sequences; the hatched box the 
human epsilon globin promoter; the open box the polyadenylation signal sequences from the HSV-I rk gene. Plasmids 
pNeIG1 and pNeIG2 were obtained by inserting the 8.0-kb EcoRI fragment of Ig C,+ locus into the single EcoRI site 
of pNc1. The plasmid maps are not drawn to scale. E, EcoRI; H, WtdIII; Pv, PvuII. 
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technique [25] with the following modifications: 
0.5 ml of DNA-calcium phosphate co-precipitate 
was added to 5 ml medium containing 1 x lo6 reci- 
pient cells growing exponentially in a 25 cm2 flask. 
For the myeloma cells, specially treated flasks 
(primaria, Falcon) were used to obtain attachment 
of more than 90% of the cells. After 24 h the 
medium was replaced with fresh nonselective 
medium (SF12 containing 15% Hyclone serum) for 
an additional 24 h. For short-term or transient ex- 
pression analysis, the cells were harvested by tryp- 
sinization. For the long term transformation assay, 
the medium was changed to selective medium con- 
taining geneticin (Gibco) at 200 fig/ml for LATK- 
and 8OOpg/ml for AG653 cells. For the liquid 
assay the medium was changed every 3 days for up 
to 2 weeks before colonies were counted using an 
inverted microscope. The semisolid medium assay 
which used 0.9% methocel has been described [26]. 
2.4. Isolation and analyses of RNA 
Total RNA extraction 48 h after transfection 
[21], RNA spot hybridization analysis [27] and 
Northern blot hybridization analysis [28] have 
been described in detail elsewhere. “P-1abelled 
DNA probes with specific activities of l-2 x 
lo8 cmp/pg were made by nick-translation [29]. 
Filter hybridization was carried out in 5 x SSC, 
50% formamide for 24 h at 42°C with 10 ng/ml 
probe as in [30]. 
3. RESULTS 
3.1. Long-term transformation assays 
First we established conditions for transforming 
LATK- mouse fibroblast and AG653 mouse 
myeloma cells with recombinant plasmids carrying 
the bacterial Tn5 encoded aminoglycoside 
phosphotransferase (aph) gene as dominant selec- 
table marker. In particular we used the pNf1 
recombinant carrying the aph gene under the 
5 ’ -transcriptional control sequences of the human 
epsilon globin gene promoter and the 
3 ’ -polyadenylation signal sequences of the HSV- 1 
tk gene. We have shown previously that similar 
hybrid gene constructs involving the human ep- 
silon globin promoter fused to the structural se- 
quences of the tk gene could functionally replace 
the tk promoter [6,21,31]. 
The strategy was then to investigate the 
Table 1 
Transformation of fibroblast LATK- and myeloma AG653 mouse cells with uph 
recombinants 
Donor 
DNAa 
Orientation 
of Ig CA 
genesb 
Recipient 
cells 
Transformation ratiosC 
Liquid assay Semisolid assay 
pN~1 - LATK- 1.0 * 0.5 1.0 f 0.5 
pNeIG1 same LATK- 1.1 + 0.4 1.0 f 0.5 
pNcIG2 opposite LATK- 1.2 + 0.6 0.8 + 0.4 
pN~1 _ AG653 1.0 + 0.7 1.0 + 0.6 
pNcIG1 same AG653 9.8 f 6.2 12 f 4.6 
pNeIG2 opposite AG653 12 f 8.0 13 + 4.0 
a Donor DNAs (O.Ol-1Ogg) were mixed with carrier salmon sperm DNA at a final 
concentration of 20 pg/ml and transformation was carried out using the calcium phosphate 
technique as described in section 2 
b With respect o the aph gene 
’ Relative to pN~1 transformation frequencies for each cell type 
Transformation frequencies for LATK- cells were in the range of 150-250 and for AG653 
0.5-2 colonies/pg pN~1 DNA. The average and standard deviations of transformation 
frequencies expressed as colonies//rg DNA were derived from the counts of 8 flasks per donor 
DNA from two independent experiments (liquid assay) or 4 plates per donor DNA from one 
experiment (semisolid assay) 
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whereas pNeIG2 carried the Ig G genes in the op- 
posite orientation (fig. 1). 
The results of the transformation of LATK- 
mouse fibroblast and AG653 mouse myeloma cells 
are shown in table 1. The transformation frequen- 
cies of LATK- cells with vector alone (pNf1) or 
with recombinants pNfIG1 and pNcIG2 were the 
same. However, transformation frequencies were 
approx. IO-times higher for the myeloma cells with 
recombinants pNeIG1 and pNeIG2 than with 
pNe1. Clearly the presence of the human Ig DNA 
resulted in cell specific differences in transforma- 
tion frequencies. Nevertheless it should be noted 
that using the same pN~1 recombinant, i.e., vector 
alone, the actual transformation frequencies of 
myeloma cells were at least SO-times lower than 
fibroblast cells. This probably reflects the lower 
capacity of myeloma cells to acquire exogenous 
DNA in a stable manner and express it. On the 
MOUSE 
other hand LATK- cells are known to be among 
the most competent mammalian cells for transfor- 
mation [32]. 
In a preliminary long-term transformation assay 
of rat myeloma Y3AG- I-2-3 cells with the plasmids 
pNe1, pNeIG1 and pNeIG2 a similar response to 
that of mouse AG653 cells was obtained. That is, 
approx. lo-times higher transformation frequen- 
cies were obtained with the pNeIG1 and pNfIG2 
than with pNf1. 
3.2. Short-term transfection assays (transient 
expression) 
To discover whether the differences in transfor- 
mation frequency of the donor DNAs in myeloma 
cells were reflected in short-term transfection 
assays, expression of the aph gene was measured 
48 h after treatment with the DNA calcium 
phosphate co-precipitates. The relative levels of 
MYdOfMl Fibr oblast Myeloma Fibroblast 
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Fig.2. Autoradiographs of spot hybridization assays of aph and actin transcripts at 48 h post-transfection of AC653 
myeloma and LATK- fibroblast mouse cells with recombinants pN~1, pNfIG1 and pNeIG2. Two-fold serial dilutions 
of total cell RNA were spotted on to nitrocellulose [27]. “P-labeled aph (the PvuII fragment carrying the structural 
gene, see fig.1) and actin (plasmid pAM91) DNAs were used as probes. 
155 
Volume 175, number 1 FEBS LETTERS September 1984 
aph RNA transcripts were determined using an 
RNA spot hybridization assay [27] and the results 
are shown in fig.2. 
In LATK- cells the levels of aph RNA 
transcripts were the same for all the 3 plasmids 
tested. However, AG653 myeloma cells transfected 
with recombinants pN6IGl or pNeIG2 had 
lo-20-times higher levels of aph RNA transcripts 
than cells transfected with pNe1. To check that 
equivalent amounts of RNA from each sample 
were spotted onto nitrocellulose, the filters were 
hybridized with pAM91 (mouse actin) or pHR28 
(human ribosomal) DNA probes. With both actin 
(fig.2) and ribosomal (not shown) probes it was 
found that there was no substantial difference in 
the level of hybridization of dots and therefore the 
amount of actin or ribosomal RNA present in 
these samples was the same. 
Northern blot hybridization analysis of RNAs 
from similar short term transfection experiments is 
shown in fig.3. Probing blots using aph DNA 
showed that in LATK- fibroblast cells approx- 
imately the same levels of the expected aph specific 
1.2-kb transcript were found for all 3 plasmids. In 
AG653 myeloma cells a different response was 
observed. Transformation with pNcIG1 and 
pNcIG2 recombinants resulted in at least lo-times 
higher levels of aph transcripts than with pNe1. 
These findings also show that the 8.0-kb Ig CA 
fragment affects gene expression by regulating the 
amount of full-length aph mRNA present in 
transfected cells (fig.3). 
Taken together, the RNA spot hybridization and 
the Northern blot hybridization analyses suggest 
that a major effect of the 8.0-kb human Ig CA 
DNA fragment on the aph gene is at the level of 
transcription. This is consistent with the presence 
of an enhancer element. However, alternative ex- 
planations, e.g., alterations in the stability of RNA 
transcripts, cannot be excluded at present. 
Fig.3. aph RNA in transfected cells. 20pg total Cell 
RNA from AG653 myeloma and LATK- fibroblast 
mouse cells transfected with the DNAs indicated were 
fractionated on a lolo formaldehyde-agarose gel, 
blotted onto nitrocellulose and probed with 32P-labelled 
PvuII DNA fragment carrying the aph gene (see fig.1). 
(a) The autoradiographs. (b) Scanning across the 1.2~kb 
band. 
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4. DISCUSSION 
Here, we have tested for the presence of an 
enhancer in the unrearranged human Ig CA locus. 
Recombinant plasmids carrying an 8.0-kb Ig G 
DNA fragment inserted in either orientation 
upstream of the aph gene were used to transfect 
mouse LATK- fibroblast and mouse AG653 
myeloma cells. Two types of assays were used. In 
long-term transformation assays, the transforma- 
tion frequencies of recipient LATK- and AG653 
cells to geneticin resistance were measured. In the 
short-term transfection assay, the levels of aph 
transcripts present in the recipient cells 48 h post- 
transfection were analyzed by RNA spot and Nor- 
thern blot hybridization. Both assays suggested the 
presence of a tissue-specific transcriptionai 
enhancer sequence encoded in the g.O-kb EcoRI 
fragment of the human Ig CA locus. Our rest&s are 
also consistent with previous findings with viral 
transcriptional enhancers that there is a good cor- 
relation between the transient levels of expression 
of the marker aph gene and subsequent ransfor- 
mation frequencies [21,32]. 
It has been suggested for the Ig heavy chain 
locus that the tissue-specific enhancer element 
might have a role in cell differentiation [lo]. This 
tissue specificity could be the result of a factor or 
factors present only in lymphoid (myeloma) cells 
which regulate human Ig expression during B cell 
ontogeny. The quantitative differences in the level 
of Ig gene expression at different stages of B cell 
development suggest that the enhancer function 
may be stage specific. Similar suggestions can be 
made for enhancers in the Ig Ck and CA loci. The 
mechanism of action of tissue- or species-specific 
enhancers is not known although some plausible 
models could involve DNA-protein interactions or 
effects on DNA conformation acting in cis [3 1,321. 
It has recently been shown that in certain 
Burkitt’s lymphoma cell lines transtocation of the 
cellular myc oncogene close to the heavy chain 
enhancer results in elevated myc gene expression 
[14]. It is tempting to speculate that such an 
enhancer element in the Ig CA locus might play a 
similar role in the transcriptional activation of the 
c-myc oncogene in the less common Burkitt’s lym- 
phomas where an 8 : 22 chromosomal trandocation 
places the Ig CA next to the myc oncogene. Such a 
chromosomal translocation has recently been 
described which also displays elevated expression 
of the c-myc oncogene 1331. Experiments are in 
progress to localize precisely and to sequence the Ig 
CA transcripticnal regulatory element. 
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